Cultivating lung tumours to personalise treatments

A team from the University of Geneva and HUG has described, for the first time, a precise methodology for developing lung tumor spheroids. A team from the Geneva University Hospitals (HUG) and the University of Geneva has described, for the first time, a precise methodology for developing lung tumor spheroids. Using cells derived from cancerous lung tissues, scientists reconstructed a miniature version of patients' tumors. The functionality of the tumor spheroids and their response to various anticancer treatments were then analyzed in the laboratory. Rapid and effective, this process identifies the most active therapeutic molecules for a specific tumor within just two to three weeks after the tissue fragments have been obtained. This paves the way for personalized cancer treatments. Read the promising results in the journal Cancers .